Gene · 1364
Papers3,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic peptides: current applications and future directions. | Signal Transduct Target Ther | 2022 | 35165272 | PubTator, text mining | PubMed |
| Metabolomics: An Emerging Approach to Understand Pathogenesis and to Assess Diagnosis and Response to Treatment in Spondyloarthritis. | Cells | 2022 | 35159358 | PubTator, text mining | PubMed |
| HIF-1α Stabilization in Flagellin-Stimulated Human Bronchial Cells Impairs Barrier Function. | Cells | 2022 | 35159204 | PubTator, text mining | PubMed |
| Recent Advances on Immunohistochemistry and Molecular Biology for the Diagnosis of Adnexal Sweat Gland Tumors. | Cancers (Basel) | 2022 | 35158743 | PubTator, text mining | PubMed |
| Single-Cell Analysis Reveals Unexpected Cellular Changes and Transposon Expression Signatures in the Colonic Epithelium of Treatment-Naïve Adult Crohn's Disease Patients. | Cell Mol Gastroenterol Hepatol | 2022 | 35158099 | PubTator, text mining | PubMed |
| Thorahcic SMARCA4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report. | Diagn Pathol | 2022 | 35151345 | PubTator, text mining | PubMed |
| The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development. | BMC Microbiol | 2022 | 35151278 | PubTator, text mining | PubMed |
| Leveraging self-assembled nanobiomaterials for improved cancer immunotherapy. | Cancer Cell | 2022 | 35148814 | PubTator, text mining | PubMed |
| ARID1A deficient undifferentiated spindle cell and rhabdoid sarcoma of the prostate: report of a unique case with emphasis on diagnostic implications. | Diagn Pathol | 2022 | 35125107 | PubTator, text mining | PubMed |
| Hypermethylation of miR-145 promoter-mediated SOX9-CLDN8 pathway regulates intestinal mucosal barrier in Crohn's disease. | EBioMedicine | 2022 | 35124427 | PubTator, text mining | PubMed |
| Urolithins: a Comprehensive Update on their Metabolism, Bioactivity, and Associated Gut Microbiota. | Mol Nutr Food Res | 2022 | 35118817 | PubTator, text mining | PubMed |
| A gradient tree boosting and network propagation derived pan-cancer survival network of the tumor microenvironment. | iScience | 2022 | 35106465 | PubTator, text mining | PubMed |
| Structurally-discovered KLF4 variants accelerate and stabilize reprogramming to pluripotency. | iScience | 2022 | 35106457 | PubTator, text mining | PubMed |
| Signatures of malignant cells and novel therapeutic targets revealed by single-cell sequencing in lung adenocarcinoma. | Cancer Med | 2022 | 35102706 | PubTator, text mining | PubMed |
| Aberrant expression of claudin-6 contributes to malignant potentials and drug resistance of cervical adenocarcinoma. | Cancer Sci | 2022 | 35100472 | PubTator, text mining | PubMed |
| Effects of butyrate- on ruminal Ca2+ transport: evidence for the involvement of apically expressed TRPV3 and TRPV4 channels. | Pflugers Arch | 2022 | 35098357 | PubTator, text mining | PubMed |
| Identification of LTF as a Prognostic Biomarker for Osteosarcoma. | J Oncol | 2022 | 35096061 | PubTator, text mining | PubMed |
| Downstream of the HOX genes: Explaining conflicting tumour suppressor and oncogenic functions in cancer. | Int J Cancer | 2022 | 35080776 | PubTator, text mining | PubMed |
| Integration of single-cell transcriptomes and chromatin landscapes reveals regulatory programs driving pharyngeal organ development. | Nat Commun | 2022 | 35075189 | PubTator, text mining | PubMed |
| Comparison between Heat-Clearing Medicine and Antirheumatic Medicine in Treatment of Gastric Cancer Based on Network Pharmacology, Molecular Docking, and Tumor Immune Infiltration Analysis. | Evid Based Complement Alternat Med | 2022 | 35069767 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1364/papers?page=53